Adeshwar Meditex Ltd (543309) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543309 | NSE: | Pharmaceuticals & Drugs | Small Cap

Adeshwar Meditex Share Price

16.50 0.00 0.00%
as on 04-Dec'25 16:59

Adeshwar Meditex Ltd (543309) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 543309 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Adeshwar Meditex

Based on:

M-Cap below 100cr DeciZen not available

Adeshwar Meditex stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
11.53
Market Cap:
23.8 Cr.
52-wk low:
15
52-wk high:
26.5

Is Adeshwar Meditex Ltd an attractive stock to invest in?

1. Is Adeshwar Meditex Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Adeshwar Meditex Ltd is a average quality company.

2. Is Adeshwar Meditex Ltd undervalued or overvalued?

The key valuation ratios of Adeshwar Meditex Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Adeshwar Meditex Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Adeshwar Meditex Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Adeshwar Meditex:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Adeshwar Meditex Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 16.8%0%28.8%17.6%14.3%11.1%7%10.1%9.6%8.5%-
Value Creation
Index
0.2NA1.10.30.0-0.2-0.5-0.3-0.3-0.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 25.2058.652.956.16664.882.479.983.784
Sales YoY Gr.--100%NA-9.7%6.1%17.6%-1.8%27.2%-3.1%4.8%-
Adj EPS 1.502.62.221.50.51.41.41.41.4
YoY Gr.--100%NA-15.2%-9.6%-22.8%-65.1%164.2%0%1.4%-
BVPS (₹) 8.9013.615.935.919.521.522.824.225.625.6
Adj Net
Profit
102.62.22.11.60.8222.12
Cash Flow from Ops. 00-1.2-5.9-13.2-2.45.83.83.8-
Debt/CF from Ops. 00-9.9-3.4-21.57.1-7.82.93.63.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 14.3%8.3%8.9%4.8%
Adj EPS -0.8%-6.3%38.9%1.4%
BVPS12.5%-6.5%6.1%5.9%
Share Price - - -14.6% -29%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
17.9026.314.8128.136.365.75.6
Op. Profit
Mgn %
7.509.47.39.87.15.26.36.55.3NAN
Net Profit
Mgn %
4.104.44.13.72.41.22.52.52.42.5
Debt to
Equity
0.900.91.31.11.10.60.50.40.3-
Working Cap
Days
18201312382943033562852752730
Cash Conv.
Cycle
830771551741862001531631620

Recent Performance Summary

Net Profit is growing at healthy rate in last 3 years 38.89%

Return on Equity has declined versus last 3 years average to 5.60%

Sales growth has been subdued in last 3 years 8.93%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Adeshwar Meditex Ltd.

Standalone Consolidated
TTM EPS (₹) 1.4 -
TTM Sales (₹ Cr.) 83.7 -
BVPS (₹.) 25.6 -
Reserves (₹ Cr.) 23 -
P/BV 0.64 -
PE 11.53 -
From the Market
52 Week Low / High (₹) 15.00 / 26.50
All Time Low / High (₹) 15.00 / 42.00
Market Cap (₹ Cr.) 23.8
Equity (₹ Cr.) 14.4
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Adeshwar Meditex:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Adeshwar Meditex - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Adeshwar Meditex

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales16.2825.1958.6052.9256.1265.9764.7682.3679.8583.71
Operating Expenses 14.4723.3053.0849.0450.6361.2661.3677.1474.6779.29
Manufacturing Costs1.960.96002.100.811.151.3410.94
Material Costs9.9719.3247.9143.6742.2154.6654.8969.5069.8174.42
Employee Cost 1.061.431.872.261.171.511.331.331.161.40
Other Costs 1.481.603.303.105.154.283.994.972.702.53
Operating Profit 1.821.895.523.885.484.713.405.225.184.43
Operating Profit Margin (%) 11.2%7.5%9.4%7.3%9.8%7.1%5.2%6.3%6.5%5.3%
Other Income 0.120.320.101.820.280.270.230.310.130.26
Interest 0.550.571.662.232.522.292.052.091.931.39
Depreciation 0.440.380.370.350.340.350.380.530.600.50
Exceptional Items 00-00000000
Profit Before Tax 0.951.253.583.122.912.341.192.902.792.79
Tax 0.370.221.020.870.790.660.400.830.780.73
Profit After Tax 0.581.042.562.252.121.680.792.072.012.07
PAT Margin (%) 3.5%4.1%4.4%4.3%3.8%2.5%1.2%2.5%2.5%2.5%
Adjusted EPS (₹)0.91.62.62.32.01.60.61.41.41.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 5.505.9113.5515.8018.9020.5830.9532.9134.9136.96
Share Capital 2.852.854.984.985.2710.5314.4314.4314.4314.43
Reserves 2.653.068.5710.8213.6410.0516.5218.4820.4822.53
Minority Interest0000000000
Debt4.855.4411.4719.9221.3220.4017.2414.5212.7911.88
Long Term Debt2.241.670.5556.135.364.072.321.061.94
Short Term Debt2.603.7710.9214.9215.1915.0413.1712.2111.739.94
Trade Payables3.143.045.996.8512.7117.9520.8316.7914.5321.21
Others Liabilities 2.011.581.701.191.793.253.422.671.741.91
Total Liabilities 15.4915.9732.7143.7654.7362.1772.4566.8963.9671.97

Fixed Assets

Gross Block5.555.896.426.857.037.358.539.7310.1610.01
Accumulated Depreciation2.323.264.074.424.745.115.506.036.637.05
Net Fixed Assets 3.232.622.352.422.282.243.033.703.532.95
CWIP 0000000000
Investments 000.020.040.080.080.100.100.100
Inventories5.294.908.4613.4714.4926.1125.3024.3226.5325.82
Trade Receivables3.844.2417.4519.6427.8727.2632.4827.9325.2734.98
Cash Equivalents 0.210.251.341.391.731.071.921.901.162.81
Others Assets 2.923.963.096.808.275.419.618.937.385.40
Total Assets 15.4915.9732.7143.7654.7362.1772.4566.8963.9671.97

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 00-1.17-5.87-0.993.15-2.445.773.843.80
PBT 003.583.122.912.341.192.902.792.79
Adjustment 001.942.442.802.352.282.322.191.60
Changes in Working Capital 00-5.64-10.56-5.88-0.83-5.341.48-0.330.25
Tax Paid 00-1.05-0.88-0.82-0.71-0.56-0.94-0.81-0.84
Cash Flow From Investing Activity 000.07-0.301.58-0.71-1.16-1.16-0.220.51
Capex 00-0.01-0.42-0.18-0.32-1.17-1.20-0.430.07
Net Investments 00-0.02-0.02-0.04-0-0.02000.10
Others 000.100.141.81-0.380.030.040.210.34
Cash Flow From Financing Activity 001.226.22-0.07-3.114.44-4.62-4.36-2.66
Net Proceeds from Shares 001.450109.75000
Net Proceeds from Borrowing 00001.13-0.77-1.29-1.76-1.260.88
Interest Paid 00-1.66-2.23-2.46-2.01-1.91-1.91-1.72-1.16
Dividend Paid 0000000000
Others 001.448.450.27-0.32-2.11-0.96-1.39-2.38
Net Cash Flow 000.110.050.53-0.660.85-0.02-0.751.65

Finance Ratio

PARTICULARSMar'14Mar'15Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)11.3118.1726.3315.3412.198.53.086.55.925.75
ROCE (%)15.7216.7528.7617.5914.2911.136.9810.069.68.53
Asset Turnover Ratio1.081.62.411.381.141.130.961.181.221.23
PAT to CFO Conversion(x)00-0.46-2.61-0.471.88-3.092.791.911.84
Working Capital Days
Receivable Days865968128155153168134122131
Inventory Days11374427691112145110116114
Payable Days13158345485102129998288

Adeshwar Meditex Ltd Stock News

Adeshwar Meditex Ltd FAQs

The current trading price of Adeshwar Meditex on 04-Dec-2025 16:59 is ₹16.50.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Dec-2025 the market cap of Adeshwar Meditex stood at ₹23.81.
The latest P/E ratio of Adeshwar Meditex as of 03-Dec-2025 is 11.53.
The latest P/B ratio of Adeshwar Meditex as of 03-Dec-2025 is 0.64.
The 52-week high of Adeshwar Meditex is ₹26.50 and the 52-week low is ₹15.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Adeshwar Meditex is ₹83.71 ( Cr.) .

About Adeshwar Meditex Ltd

Adeshwar Meditex is an Indian company, engaged in the manufacturing of surgical dressings and external preparations products of Wound care & Wound management including sterile surgical wound dressing, tulle dressing, medical disposable, adhesive bandages, absorbent gauze, plaster, disinfectants, medical kits etc. The company is an ISO 13485:2016 certified Company. It has manufacturing facility situated at Deewan Industrial Estate, Palghar District. Its state-of-the-art manufacturing plant follows WHO-GMP, CE, ISO guidelines and it is backed by an advanced production facility, which is fitted with latest machinery and well organized and arranged sterilization facilities.

It endeavors to maintain safety in its premises by adhering to key safety norms. Its manufacturing facility also has sophisticated facilities for quality testing, research & development, storage and packaging. It has an in-house R&D facility for on-site process improvement and for bettering its present products offered as well as products under innovation and testing laboratory which ensures that its products are certified and any major defects in the products are identified on real time basis and rectified before the final dispatch. It has dedicated teams actively involved in R&D and QC/ QA Lab activities. These functions have impeccably streamlined and thus assure swift production and post-production processes and enable it to support its growth strategy by developing new products and processes which enhance its product range. The focus of its R&D has been to strive for continuous process improvements which will cater to the requirements of global patients from the point of view of effectiveness and safety besides achieving manufacturing cost efficiencies.

Business area of the company

The company is one of the major, trusted, cGMP, CE, ISO 9001-2008 Certified manufacturer and exporter in the field of sterile surgical wound dressing products and medical disposables.

Major events in the history:

  • 1997: Started business as prop. Concern Adeshwar Meditex.
  • 2007: Incorporation of the Company and subsequently takeover of Proprietorship firm of our promoter Siddharth Talati, Adeshwar Meditex.
  • 2015: The company Crossed turnover of Rs 25 crore.
  • 2018: The company Crossed turnover of Rs 50 crore.
  • 2021: Conversion of Company from “Private Limited” to “Public Limited”.
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×